These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38746879)

  • 1. Expanding TPD Horizons: Innovative Strategies Targeting BCL6 and SMARCA2.
    Kargbo RB
    ACS Med Chem Lett; 2024 May; 15(5):576-578. PubMed ID: 38746879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Precision Oncology: The Role of TPD in Targeting CDK2 and Beyond.
    Kargbo RB
    ACS Med Chem Lett; 2024 Jul; 15(7):1004-1006. PubMed ID: 39015280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approaches to targeted protein degradation technologies in drug discovery.
    Xue Y; Bolinger AA; Zhou J
    Expert Opin Drug Discov; 2023 Apr; 18(4):467-483. PubMed ID: 36895136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances of targeted protein degradation technology and its applications in diseases therapy].
    Chen S; Yang H; Jiang J; Yu S; Li T; Ge S
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3915-3932. PubMed ID: 34841795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted protein degradation in drug development: Recent advances and future challenges.
    Song J; Hu M; Zhou J; Xie S; Li T; Li Y
    Eur J Med Chem; 2023 Dec; 261():115839. PubMed ID: 37778240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted protein degradation directly engaging lysosomes or proteasomes.
    Kim J; Byun I; Kim DY; Joh H; Kim HJ; Lee MJ
    Chem Soc Rev; 2024 Apr; 53(7):3253-3272. PubMed ID: 38369971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Protein Degradation Technology and Nanomedicine: Powerful Allies against Cancer.
    Lin JY; Liu HJ; Wu Y; Jin JM; Zhou YD; Zhang H; Nagle DG; Chen HZ; Zhang WD; Luan X
    Small; 2023 May; 19(18):e2207778. PubMed ID: 36693784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted protein degradation in cancers: Orthodox PROTACs and beyond.
    Li J; Chen X; Lu A; Liang C
    Innovation (Camb); 2023 May; 4(3):100413. PubMed ID: 37033156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advancements in targeted protein knockdown technologies-emerging paradigms for targeted therapy.
    Joshi M; Dey P; De A
    Explor Target Antitumor Ther; 2023; 4(6):1227-1248. PubMed ID: 38213543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas.
    Mancarella C; Morrione A; Scotlandi K
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential of Proteolytic Chimeras as Pharmacological Tools and Therapeutic Agents.
    Coll-Martínez B; Delgado A; Crosas B
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunities and challenges of protein-based targeted protein degradation.
    Shen F; Dassama LMK
    Chem Sci; 2023 Aug; 14(32):8433-8447. PubMed ID: 37592990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROTACs: An Emerging Therapeutic Modality in Precision Medicine.
    Nalawansha DA; Crews CM
    Cell Chem Biol; 2020 Aug; 27(8):998-1014. PubMed ID: 32795419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing targeted protein degradation for metabolic diseases therapy.
    Zhou QQ; Xiao HT; Yang F; Wang YD; Li P; Zheng ZG
    Pharmacol Res; 2023 Feb; 188():106627. PubMed ID: 36566001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefining the Scope of Targeted Protein Degradation: Translational Opportunities in Hijacking the Autophagy-Lysosome Pathway.
    Cassidy K; Zhao H
    Biochemistry; 2023 Feb; 62(3):580-587. PubMed ID: 34569233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic KLHL20 ligand to validate CUL3
    Farrell BM; Gerth F; Yang CR; Yeh JT
    Genes Dev; 2022 Sep; 36(17-18):1031-1042. PubMed ID: 36328355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted protein degradation at the host-pathogen interface.
    Grohmann C; Marapana DS; Ebert G
    Mol Microbiol; 2022 Mar; 117(3):670-681. PubMed ID: 34816514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin-Proteasome system.
    Xie H; Zhang C
    Eur J Med Chem; 2024 Mar; 267():116168. PubMed ID: 38310686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-Molecule Hydrophobic Tagging: A Promising Strategy of Druglike Technology for Targeted Protein Degradation.
    Xie S; Zhu J; Li J; Zhan F; Yao H; Xu J; Xu S
    J Med Chem; 2023 Aug; 66(16):10917-10933. PubMed ID: 37535706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROTAC targeted protein degraders: the past is prologue.
    Békés M; Langley DR; Crews CM
    Nat Rev Drug Discov; 2022 Mar; 21(3):181-200. PubMed ID: 35042991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.